ConductScience.org, home

Paper · 35301281

References430

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110485821Acute toxicity of an anti-Fas antibody in mice.Toxicol Pathol1999https://conductscience.org/library/papers/10485821PubMed
216619028Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression.EMBO J2006https://conductscience.org/library/papers/16619028PubMed
330005714CART cells are prone to Fas- and DR5-mediated cell death.J Immunother Cancer2018https://conductscience.org/library/papers/30005714PubMed
411418480The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.Blood2001https://conductscience.org/library/papers/11418480PubMed
517290285ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death.Cell Death Differ2007https://conductscience.org/library/papers/17290285PubMed
625723171Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.Cell2015https://conductscience.org/library/papers/25723171PubMed
77964507Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane.J Exp Med1994https://conductscience.org/library/papers/7964507PubMed
822917034Cyclosporine A and bromocriptine attenuate cell death mediated by intracellular calcium mobilization.BMB Rep2012https://conductscience.org/library/papers/22917034PubMed
928424702Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance.Front Immunol2017https://conductscience.org/library/papers/28424702PubMed
1025918278Toxicities of Immunotherapy for the Practitioner.J Clin Oncol2015https://conductscience.org/library/papers/25918278PubMed
1134223817Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2.Elife2021https://conductscience.org/library/papers/34223817PubMed
1212535213Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8.J Invest Dermatol2003https://conductscience.org/library/papers/12535213PubMed
139643529Inhibition of systemic TNF-alpha cytotoxicity in cancer patients by D-peptidoglycan.Med Oncol1998https://conductscience.org/library/papers/9643529PubMed
1415004554Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury.Nat Med2004https://conductscience.org/library/papers/15004554PubMed
1530692847Multiple Sclerosis: Diagnosis and Differential Diagnosis.Noro Psikiyatr Ars2018https://conductscience.org/library/papers/30692847PubMed
1631564969Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies.Cancer Manag Res2019https://conductscience.org/library/papers/31564969PubMed
1719596991Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand.J Immunol2009https://conductscience.org/library/papers/19596991PubMed
189267021Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3.Cell1997https://conductscience.org/library/papers/9267021PubMed
1930413827Cytokines in clinical cancer immunotherapy.Br J Cancer2019https://conductscience.org/library/papers/30413827PubMed
209144461Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back.J Immunol1997https://conductscience.org/library/papers/9144461PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/35301281/references